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Abstract 
Background. Boron nitride nanotubes (BNNTs) represent a new opportunity for drug delivery 
and clinical therapy. The present work has the objective to investigate pectin-coated BNNTs 
(P-BNNTs) for their biocompatibility on macrophage cultures, since these cells are among the 
first components of the immune system to interact with administered nanoparticles. 
Methods. As first step, the potential toxicity of P-BNNTs is verified in terms of proliferation, 
oxidative stress induction and apoptosis/necrosis phenomena. Thereafter, the modulation of 
immune cell response following P-BNNT exposure is evaluated at gene and protein level, in 
particular focusing on cytokine release. Finally, P-BNNT internalization is assessed through 
transmission electron microscopy and confocal microscopy. 
Results. The results proved that P-BNNTs are not toxic for macrophages up to 50 µg/ml after 
24 h of incubation. The cytokine expression is not affected by P-BNNT administration both at 
gene and protein level. Moreover, P-BNNTs are internalized by macrophages without 
impairments of the cell structures. 
Conclusions. Collected data suggest that P-BNNTs cause neither adverse effects nor 
inflammation processes in macrophages. 
General significance. These findings represent the first and fundamental step in immune 
compatibility evaluation of BNNTs, mandatory before any further pre-clinical testing. 
 
Keywords: Boron nitride nanotubes; macrophages; immune system; cytocompatibility 
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1. Introduction 
Boron nitride nanotubes (BNNTs) have intensively been explored over the last 20 years due 
to their extraordinary properties, that include oxidation and heat resistance, notable 
hydrophobicity, good electrical insulation in combination with high thermal conductivity, and 
piezoelectricity [1]. These features make BNNTs suitable for many applications ranging from 
the automotive and aerospace sectors to the biomedical field. Furthermore, the combination of 
these nanotubes with engineered materials and systems improves the efficiency of new 
products [2, 3]. 
Biomedical field takes advantage of BNNTs for many applications, including pH sensing [4], 
fabrication of advanced implants [5], bioimaging [6], and electrical stimulation [7]. Moreover, 
BNNTs have been also proposed as nanocarriers for biomolecules as DNA [8] and for 
anticancer-drugs [9]. Toxicological investigations demonstrated that BNNTs exhibit optimal 
biocompatibility with several cell lines such as myoblasts, human neuroblastoma cells, 
pheochromocytoma cells [7] and endothelial cells [10]. According to Li e al., not only 
BNNTs are safe in mesenchymal stem cells, but indeed they are able to improve their 
commitment towards osteoblasts [11]. Chen et al. compared the cytocompatibility of carbon 
nanotubes (CNTs) and BNNTs on human embryonic kidney 293 cells, confirming that CNTs 
cause apoptosis and prevent proliferation, while BNNTs do not induce any toxic effects [8]. 
Very recently, Emanet et al. extensively investigated carbohydrate-modified BNNTs, 
highlighting different up-take and toxicity profiles in cancer cells with respect to normal cell 
lines, further corroborating the potentiality of BNNTs in cancer therapy [12]. 
In vivo biocompatibility evaluations are still relatively rare. One of the first animal studies 
reported on the biodistribution of BNNTs functionalized with glycol chitosan and 
radiolabeled with 
99m
Tc [13]. This study confirmed the non-toxic behavior of BNNTs, which 
were accumulated in liver, spleen and gut, and were excreted through kidney. Our group 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
  
4 
 
carried out a systematic toxicological analysis of BNNTs in rabbits. The results proved that 
animals injected with a BNNT dose of 10 mg/kg until 7 days reveal no harmful effects on 
liver, kidney, and haematic functionality [14]. More recently, BNNTs were tested on another 
in vivo model, freshwater planarians, in order to assess their effects on de novo tissue 
regeneration [15]. BNNTs, dispersed in gum Arabic solutions, neither caused DNA damage 
and apoptosis nor interfered with animal regeneration. 
Despite several studies demonstrated the biosafety of BNNTs, the examination of the 
interactions between BNNTs and immune system is still missing, and their immune toxicity 
investigation is absolutely compulsory before any progress into pre-clinical studies. 
Macrophages, the phagocytic cells of the immune system, frequently first internalize 
nanoparticles which could produce undesirable effects on immune system [16]. Many 
nanoparticles, even though biocompatible, can activate an inflammatory response or 
immunosuppression following interaction with immune cells, thus voiding their in vivo testing 
and further clinical experimentation [17]. Examples of nanoparticles able to induce immune 
stimulation include titanium dioxide nanoparticles [18], zinc oxide nanoparticles [19], silica 
nanoparticles [20], and silver nanoparticles [21]. CNTs, moreover, have been proven to 
induce inflammation and granulomas into the abdominal cavity of mice [22]. 
All these data suggest the necessity of a great care introducing innovative nanoparticles in 
clinical trials, with particular attention to be given to their immune compatibility. The present 
work represents the first investigation on immunomodulation mediated by BNNTs, a 
necessary requirement to further exploit BNNTs as therapeutic/diagnosis agent. Pectin-
stabilized BNNTs have been tested on RAW 264.7 macrophages and their impact in terms of 
cytocompatibility and potentially adverse immune reactions has been thoroughly analyzed. 
 
2. Materials and methods 
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2.1 P-BNNT preparation 
High-purity (90%) multi-walled BNNTs were obtained through a carbon-free chemical vapor 
deposition technique as previously described [23]. 1 mg of BNNTs were dispersed in 1 ml of 
a solution of apple-derived pectin (Sigma, 1 mg/ml in MilliQ water) and sonicated with an 
ultrasonic homogenizer (Bandelin) at 8 W for 20 min at 4°C. Thereafter, the dispersion was 
purified through centrifugation (3 times at 14000 rpm for 5 min) in order to remove excess 
polymer, and finally the pellet of pectin-wrapped BNNTs (P-BNNTs) was resuspended in 
MilliQ at a concentration of 1 mg/ml. The characterization of P-BNNTs was carried out using 
scanning electron microscopy (SEM, Helios NanoLab 600i, FEI) and transmission electron 
microscopy (TEM, Zeiss Libra 120 Plus). The analysis of particle size distribution and Z-
potential was performed by means of a Nano Z-Sizer 90 (Malvern Instrument). 
2.2 Cytocompatibility assays 
Cytocompatibility of P-BNNTs has been evaluated on mouse macrophages RAW 264.7 
(ATCC® TIB71™) at doses in the range 0-50 µg/ml, established basing on previous 
biological investigations carried out on the same typology of nanotubes [24]. 
The complete expansion medium of the cells was composed by high-glucose Dulbecco’s 
Modified Eagle’s Medium (DMEM), 10% fetal bovine serum, 100 U/ml penicillin, 100 
mg/ml streptomycin. The seeding density of cells (at fourth passage) for all the assays was 
5000 cells/cm
2
. After 24 h from seeding, cells were treated with P-BNNTs in growth medium 
for 24 h. 
WST-1 assay ((2-(4-iodophenyl)-3-(4-nitophenyl)-5-(2,4-disulfophenyl)-2H-tetrazoilium 
monosodium salt, BioVision) was performed to evaluate cell metabolism. For this test, 10 µl 
of the WST-1 solution and 100 µl of the fresh medium were incubated with cells seeded in 
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96-well plates (n = 6) for 90 min and then the absorbance of the supernatants was measured at 
450 nm with a microplate reader (Victor3, Perkin Elmer). 
For the Quant-iT™ PicoGreen® dsDNA assay (Molecular Probes), cell cultures (n = 6) were 
lysed and incubated with the reagents in dark at room temperature following the 
manufacturer’s instructions. The fluorescence of the solutions was finally measured in 96-
well black plates through the microplate reader (excitation 485 nm, emission 535 nm). 
Reactive oxygen species (ROS) production was assessed with the 6-carboxy-2',7'-
dichlorodihydrofluorescein diacetate bis(acetoxymethyl)-ester (C-DCF-DA; Molecular 
Probes), which is converted in its fluorescent form by ROS. Cells, seeded in 12-well plates 
(n = 6), were washed with Hanks’-buffered saline and incubated for 30 min with C-DCF-DA 
(25 μM) at 37°C in Hank’s buffer. Thereafter, cells were scraped and resuspended in Hank’s 
buffer and the fluorescence was measured by flow-cytometry (BD Accuri™ C6) at 485 nm 
excitation and 525 nm emission reading 10000 events for each sample. 
Annexin V-FITC Apoptosis Detection kit (Sigma) was used to quantify apoptotic/necrotic 
cells. Briefly, cells plated in 12-well plates (n = 6) were collected and stained with annexin V-
FITC and propidium iodide following the manufacturer’s instructions. After 10 min of 
incubation at room temperature, 10000 events per sample were analyzed through flow 
cytometry. 
2.3 Cytokine detection 
To estimate the cytokine production following appropriate treatments, RAW 264.7 were 
seeded in 24-wells plate and after 24 h were incubated with 1 µg/ml of lipopolysaccharides 
from Escherichia coli 055:B5 (LPS, Sigma) as a positive control, or with 5 and 10 μg/ml of 
BNNTs. Cytokine release was estimated through enzyme-linked immunosorbent assay 
(ELISA, Millipore), and only for this test the cell seeding density was 100000 cells/cm
2
. Cell 
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culture supernatants were harvested after the treatment in order to detect interleukin 6 (IL-6), 
interleukin 10 (IL-10) and tumor necrosis factor α (TNF-α) according to the manufacturer's 
protocol. Moreover, cells were collected and processed through Pierce™ BCA Protein Assay 
Kit (Fisher Scientific) to determine the total cellular protein content, which was used to 
normalize the concentration of cytokines of each sample (n = 6). 
Quantitative real time RT-PCR (qPCR) was performed for gene transcription analysis. At the 
end of the treatment, the cells, seeded in 24-wells plates (n = 6), were lysed to extract the 
RNA with the RNeasy® Plus Mini kit (QIAGEN) using the automated robotic workstation 
QIAcube (QIAGEN). Following the assessment of RNA purity and concentration with a 
Nanodrop spectrophotometer (Thermo Scientific), RNA (500 ng) was reverse-transcribed by 
using the iScriptTM Reverse Transcription Supermix (Bio-Rad). The obtained cDNA was 
amplified through the Cytokines & Chemokines RT
2
 Profiler PCR Array (Qiagen, PAMM-
150Z). The program temperature performed on the thermocycler CFX Connect™ Real-Time 
PCR Detection System (Bio-Rad) was the following: one cycle at 95°C for 10 min, 40 cycles 
at 95°C for 15 s and 60°C for 1 min, and finally a temperature ramp from 65°C to 95°C, with 
0.5°C/s increments. The ∆∆Ct method was used for the relative quantification of the target 
genes. The gene list of the 84 target genes and 5 reference genes analyzed is reported in Table 
S1 of Supplementary Material. 
2.4 P-BNNT / RAW 264.7 interaction assessment 
SEM observations were performed to qualitatively analyze the cell shape and surface 
following P-BNNT treatments. After a 24 h incubation with 10 µg/ml of P-BNNTs, cultures 
were fixed with 4% paraformaldehyde in PBS for 30 min at 4°C and then with 2.5% 
glutaraldehyde in de-ionized water for 2 h at 4°C. After dehydration in a series of increasing 
ethanol concentrations and air-drying, the samples were sputter-coated with a thin gold layer 
and observed using SEM. 
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TEM was performed on a Zeiss Libra 120 Plus instrument operating at 120 kV and equipped 
with an in-column omega filter. Control and treated (10 μg/ml P-BNNTs for 24 h) 
macrophage cultures were fixed as monolayers with a solution of 1.5% glutaraldehyde in 
cacodylate buffer. Thereafter, cells were scraped, centrifuged, and treated as pellets with a 
standard embedding protocol. Briefly, samples were post-fixed in 2% osmium tetroxide in 
cacodylate buffer, rinsed and stained en bloc with 3% uranyl acetate solution in 20% ethanol. 
Finally, samples were dehydrated and embedded in epoxy resin (Epon 812, Electron 
Microscopy Science), that was baked for 48 h at 60°C. Thin sections of 90 nm thickness were 
cut with a UC7 Leica ultramicrotome and collected on 300 meshes copper grids. 
To verify the P-BNNT uptake by macrophages, laser scanning confocal microscopy was 
carried out. Cells, plated on Ibidi 60 µ-Dish (35 mm), were treated with 10 µg/ml of P-
BNNTs and fixed after 24 h with 4% paraformaldehyde in PBS for 30 min at 4°C. Standard 
staining of f-actin and cell nucleus was performed with Oregon Green® 448 phalloidin (5 µl 
each 200 µl of medium) and Hoechst 33342 (1 µl each 1 ml of medium), respectively. 
Cultures were finally observed under confocal microscope (C2s, Nikon). P-BNNT 
observation was possible by exciting sample at 642 nm and collecting emitted fluorescence 
between 670 nm and 750 nm. 
Co-localization of P-BNNTs with lysosomes was evaluated through the LysoTracker® 
staining (Molecular Probes). Cells, at the end of the P-BNNT treatment (10 µg/ml for 24 h), 
were incubated with 100 nM of the lysosome probe and with Hoechst 33342 for 1 h, and then 
observed under confocal microscope. 
Stiffness of cell membrane was evaluated through SICM as described by Marino et al. [25]. 
Briefly, 200 nm borosilicate glass pipettes were mounted on a piezo-translator stage 
(Nanocube P-611 3S with a driver E-664, Physik Instrumente). A pressure (ΔP) was applied 
by a syringe controlled by a micrometric screw. When the pipette approached a sample along 
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the Z axis, a current decrease occurred because of a smaller conducting space. The pipette was 
stopped when the ion current (I) has been reduced to a preset percentage of its maximum 
value (I0, measured far enough from the sample). Local elastic modulus was deduced by 
recording the ion current as a function of the vertical pipette position (I/Z curve). Signals were 
filtered thanks to a low-pass filter (400 Hz). The LabVIEW 8.2.1 software was used for both 
the scan control and the data analysis. Eight cells per experimental condition were analyzed, 
and Young's modulus was measured in 4 different points of each cell, in the perinuclear zone, 
by applying a stress ΔP = 3000 Pa. 
2.5 Statistical analysis 
Statistical analysis was performed through KaleidaGraph (Sinergy Software) using one-way 
ANOVA followed by Bonferroni's post-hoc test, while qPCR results were analyzed with Bio-
Rad CFX Manager software. Data distributions from SICM were tested with the Shapiro 
normality test, and subsequently with Wilcoxon signed-rank test. All data were considered 
statistically significant at p-values < 0.05. 
 
3. Results 
3.1 Pectin-coated BNNTs 
P-BNNTs are well dispersed in aqueous solutions, as demonstrated by SEM images at low 
(Figure 1a) and high (Figure 1b) magnification. TEM imaging highlighted the typical shape of 
multi-walled BNNTs (Figure 1c) and electron diffraction pattern showed the hexagonal 
structure of layers comprising them (Figure 1d). 
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Figure 1. SEM imaging of P-BNNTs at low (a) and high (b) magnification. Morphology and structure 
of P-BNNTs are confirmed by TEM bright field image (c) and electron diffraction pattern (d). 
Dynamic light scattering (e) and Z-potential (f) analysis of P-BNNT dispersions. 
 
The hydrodynamic diameter (DH) distribution obtained by dynamic light scattering is reported 
in Figure 1e, and presents an average value of about 500 nm. The model described by Nair et 
al. [26] has been used for the estimation of the average nanotube length L corresponding to 
the experimental DH, by exploiting the following equation: 
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32.0)ln( 

d
L
L
DH
         (1) 
where d is the diameter of the nanotube (d = 50 nm). By using this equation we obtained an 
average P-BNNT length of 2.0 µm (with a range of 1.0 - 4.0 µm), confirming qualitative 
evidences provided by the SEM and TEM observations. 
The Z-potential resulted -33.3±6.0 mV (Figure 1f), highlighting an excellent stability of the 
dispersion even after several months since the preparation. Energy-filtered transmission 
electron microscopy (EFTEM), provided in Supplementary Material, confirmed the presence 
of a pectin layer wrapping the BNNTs, suggested by the presence of carbon surrounding the 
P-BNNTs that stabilizes the nanotubes in aqueous solution (Figure S1). 
3.2 Pectin-coated BNNT cytocompatibility 
Cytocompatibility tests were performed to evaluate P-BNNT effects on proliferation and 
viability of macrophages after an acute 24 h treatment with increasing concentrations of 
nanotubes (0, 5, 10, 20 and 50 μg/ml). 
WST-1 results demonstrated that cell metabolism is not altered by P-BNNT treatment at all 
the considered concentrations (p > 0.05) with respect to the control cultures (Figure 2). 
Proliferation rate was assessed using Quant-iT™ PicoGreen® dsDNA assay, enabling the 
quantification of the total dsDNA in the cultures. Once again, obtained data indicate no 
differences in terms of DNA concentration (and, therefore, of cell number) in the treated 
samples (p > 0.05 in all the cases, Figure 2). 
Flow-cytometry assessment of ROS production following P-BNNT administration further 
corroborated the hypothesis of absence of negative effects: after a 24 h exposure, ROS levels 
in all the treatments were statistically non-different from the control cultures (p > 0.05 in all 
the cases, Figure 2). 
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Figure 2. Cytocompatibility evaluation on RAW 264.7 macrophages following incubation with 0-50 
μg/ml of P-BNNTs for 24 h: metabolic activity, ds-DNA content in cultures, ROS production. 
 
Flow-cytometry quantification of necrotic/apoptotic phenomena finally demonstrated that an 
acute treatment with P-BNNTs, up to 50 μg/ml, do not cause a statistically significant 
increase of necrotic, early apoptotic and late apoptotic cells in comparison to control culture 
(p > 0.05). Scatter plots of a representative experiment are depicted in Figure 3, while detailed 
quantifications are reported in Table 1. 
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Figure 3. Flow-cytometry evaluation of apoptosis in RAW 264.7 macrophages treated for 24 h with 0-
50 μg/ml of P-BNNTs. 
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Table 1. Quantification of viable, necrotic, early apoptotic, and late apoptotic cells after 24 h of 
incubation with increasing concentrations of P-BNNTs. 
 
3.3 Effects of P-BNNTs on immune response 
The potential immunomodulation effects of P-BNNTs on macrophages have been 
investigated through ELISA to assess the cytokine release, and through qPCR for the analysis 
of transcription of cytokine and chemokine genes. We decided to evaluate 5 and 10 µg/ml of 
BNNTs for all the subsequent experiments, i.e., safe concentrations which are one order of 
magnitude lower with respect to the maximum concentration tested in the cytocompatibility 
assays. Macrophages have been thus treated for 24 h with P-BNNTs or stimulated with 
lipopolysaccharides (LPS, 1 µg/ml) as positive control, and the effects were compared to the 
behavior of non-treated control cultures. The results obtained from ELISA (Figure 4a) 
revealed that IL-6 secretion normalized to the total protein content was not significantly 
affected by both concentrations of P-BNNTs with respect to the control (88±35 pg/μg for P-
BNNTs 5 μg/ml, 69±16 pg/μg for P-BNNTs 10 μg/ml, 67±47 pg/μg for the control), while 
significant release occurred in the LPS-treated culture (5.965±0.746 ng/μg, p < 0.05). Also in 
the case of IL-10 release, P-BNNTs did not cause statistically significant alterations in 
comparison with untreated cultures (0.729±0.311 ng/μg for P-BNNTs 5 μg/ml, 1.270±0.829 
ng/μg for P-BNNTs 10 μg/ml, 0.682±0.073 ng/μg for the control; on the contrary 
  
P-BNNT 
concentration 
(µg/ml) 
  
Viable cells 
(%) 
  
  
Necrotic cells 
(%) 
  
  
Early 
apoptotic cells 
(%) 
  
  
Late apoptotic 
cells (%) 
  
0 92.1±0.1 5.8±0.6 0.3±0.2 1.8±0.3 
5 85.3±3.2 11.5±2.0 0.7±0.1 2.5±0.3 
10 88.8±0.7 7.8±1.3 1.0±1.0 2.2±1.5 
20 89.0±0.1 7.4±0.1 2.2 ±0.1 1.5±0.1 
50 92.0±2.4 4.4±0.6 1.5 ±1.2 2.1±1.7 
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28.679±2.544 ng/μg for LPS treatment, p < 0.05). Finally, P-BNNT treatment did not 
significantly alter even the release of TNF-α in macrophages treated with both 5 μg/ml 
(6.929±0.069 ng/μg) and 10 μg/ml (7.398±0.169 ng/μg) of P-BNNTs with respect to the 
control (5.749±0.086 ng/μg). Also in this case, LPS caused instead a significant release of 
TNF-α (21.118±5.091 ng/μg, p < 0.05). 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
  
16 
 
Figure 4. Cytokine release from macrophages incubated for 24 h with 5 and 10 μg/ml of P-BNNTs or 
with 1 μg/ml of LPS and compared to control cultures (* p < 0.05) (a). Scatter plots of up- (in red) and 
down- (in green) regulated genes in RAW 264.7 stimulated with 1 μg/ml of LPS (b) or with 10 μg/ml 
of P-BNNTs (c) with respect to control cultures (regulation threshold 4.0). 
 
Figure 4b-c shows the results of the transcription profile of the main cytokine and chemokine 
genes involved in an immune reaction. Gene transcription levels are reported as scatter data 
depicted in red for up-regulated genes, in green for down-regulated genes, and in black for no 
significant change in transcription level. Lines show the 4-fold up- (red) and down- (green) 
regulation threshold. The comparison control vs. P-BNNT treatment (Figure 4b) at the highest 
concentration (10 μg/ml) demonstrated that P-BNNTs did not induce statistically significant 
changes in the transcription level of the 84 analyzed genes, except for interleukin 1β (Il1b) 
which was significantly down-regulated (4.1 folds, p < 0.05). Conversely, the LPS treatment 
caused statistically significant up-regulation of 26 genes and down-regulation of 11 genes 
related to the immune response with respect to the non-treated cultures (Figure 4c, p < 0.05). 
Table 2 shows the list of the investigated genes along with the up- or down-regulation fold. 
  
Target Fold difference with respect to the 
control 
 
 LPS (1 µg/ml) P-BNNTs (10 µg/ml) 
Adipoq -5.2* -2.0 
Bmp6 -1.1 -1.6 
Bmp7 -2.54 -2.1 
Cd1 -15.9* -1.9 
Cd11 -1.3 1.9 
Cd12 39.3* 1.6 
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Cd17 -1.2 -1.1 
Cd2 100.0* 2.2 
Cd22 8.6* -1.3 
Cd24 -6.5* -1.9 
Cd3 59.6* 2.1 
Cd4 105.6* 2.3 
Cd5 139.5* -1.5 
Cd7 579.2* 1.8 
Cntf -3.9 1.1 
Csf1 8.5* -1.1 
Csf2 9.9* -1.9 
Csf3 3800.9* -1.6 
Ctf1 8.6* 2.4 
Cx3cl1 -2.8 -2.9 
Cxcl1 6.9* 1.1 
Cxcl10 -2.1 -1.5 
Cxcl13 -4.5* -1.8 
Cxcl16 -2.0 -1.3 
Cxcl3 11596.1* -3.5 
Gpi1 -1.1 -1.2 
Ifna2 -4.4* -1.1 
Il10 18.2* -1.1 
Il11 16.4* -2.4 
Il15 1.6 1.1 
Il16 -1.3 1.1 
Il17f -1.4 -1.6 
Il18 -1.4 -1.5 
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Il1a 3609.1* -1.7 
Il1b 670.2* -4.1* 
Il1rn 57.1* 2.4 
Il2 -3.6 -1.3 
Il23a 3.3 -2.9 
Il27 18.4* 1.4 
Il4 -7.1* -2.5 
Il5 -4.9* -3.3 
Il6 11760.3* -1.2 
Il7 2.6 -1.1 
Il9 -3.5 -1.7 
Lif 36.5* 1.5 
Lta 2.4 -1.5 
Ltb -1.1 -1.1 
Mif -1.1 -1.1 
MStn -8.3* -2.9 
Nodal -1.4 -1.8 
Osm 16.3* 1.1 
Pf4 23.8* 1.1 
PPbp 7090.9* 1.2 
Spp1 2.4 -1.1 
Thpo -4.9* -2.1 
Tnf 4.0* 1.1 
Tnfrsf11b -11.9* -2.8 
Tnfsf10 -7.4* -1.4 
Tnfsf11 -2.3 -1.8 
Tnfsf13b -1.5 1.1 
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Vegfa 10.3* -1.1 
Table 2. List of up- or down-regulated genes following treatment with LPS or P-BNNTs with respect 
to the control. (* p < 0.05). 
 
3.4 P-BNNTs / macrophages interaction 
Nanotubes/macrophages interactions have been investigated through SEM, TEM and confocal 
microscopy after a 24 h treatment with 10 µg/ml of P-BNNTs. Mechanical properties of the 
cells following P-BNNT uptake have been evaluated with scanning ion conductance 
microscopy (SICM). 
 
Figure 5. SEM images of macrophages incubated with 10 μg/ml of P-BNNTs for 24 h at low (a) and 
high (b) magnification. TEM image of the same culture showing P-BNNT internalization (white 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
  
20 
 
arrows indicate single and aggregated P-BNNTs) at low (c) and high (d) magnification; electron 
diffraction pattern of P-BNNTs inside the cells (e). 
 
SEM images showed that P-BNNTs do not qualitatively affect the morphology of 
macrophages with respect to control cultures (Figure 5a, control not shown). Moreover, the 
images at higher magnification (Figure 5b) demonstrated the presence of nanotubes strictly 
entrapped in membrane protrusions. 
TEM analysis revealed that about 65% of treated cells appear positive for the internalization 
of P-BNNTs, that formed small aggregates (from one to three nanotubes) in the perinuclear 
regions of the cytoplasm (Figure 5c). Figure 5d shows P-BNNTs inside the cell at higher 
magnification, while in Figure 5e the correspondent electron diffraction pattern confirms the 
structure of internalized P-BNNTs. 
Laser scanning confocal microscopy further confirmed the P-BNNT internalization by 
macrophages. Figure 6a reveals single channel and merged image of a single confocal 
acquisition and side projections of a confocal Z-stack, demonstrating P-BNNT internalization 
in the cell cytoplasm (actin in green, P-BNNTs in red, nuclei in blue). Finally, LysoTracker® 
staining highlighted that P-BNNTs do not co-localize with lysosomes (quantitative evaluation 
showed a Pearson’s coefficient R = 0.14), as suggested by Figure 6b, showing 3D rendering 
of acquisitions of lysosomes (in green), P-BNNTs (in red) and nuclei (in blue). 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
  
21 
 
 
Figure 6. Laser confocal analysis of P-BNNT uptake: f-actin in green, P-BNNTs in red, nuclei in blue 
(a); 3D rendering of lysosomes / P-BNNTs co-localization investigation: lysosomes are shown in 
green, P-BNNTs in red, nuclei in blue (b). 
 
SICM analysis eventually highlighted a change in cell membrane mechanical properties upon 
P-BNNT internalization. Macrophages undergone a 24 h treatment with 10 µg/ml of P-
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BNNTs (and thus extensively internalizing them) presented a membrane Young's modulus 
E = 2375±680 kPa, significantly increased if compared to that one of the control cells 
(840±335 kPa). 
 
4. Discussion 
The aim of this work is to provide preliminary data about BNNT immune compatibility, thus 
our investigation has been focused on the assessment of the effects of BNNTs on RAW 264.7 
macrophages. 
In order to improve water-stabilization of highly hydrophobic BNNTs, we successfully 
exploited pectin as a wrapping polymer. Pectin is a natural polysaccharide of vegetable origin 
composed by D-galacturonic acid units [27], widely exploited for the stabilization of different 
kinds of nanomaterials in aqueous environments, including silver nanoparticles [28] and 
silica-coated magnetic nanoparticles [29], and as bulk material for the preparation of 
nanocarriers for drug delivery [30]. The issue of low water dispersibility of BNNTs is object 
of intensive research, that led to the exploitation of several approaches including PEGylated 
phospholipids, glycol chitosan, flavin mononucleotides, etc. [7]. Here, the use of pectin as a 
surfactant was found to considerably improve the water dispersion and stability of BNNTs, 
which were stable for several months since the preparation (no variation in terms of 
hydrodynamic size distribution and Z-potential). 
Once the stability of P-BNNTs has been confirmed, experiments were directed to the 
cytocompatibility examination of P-BNNTs on mouse macrophages RAW 264.7. 
Macrophages have been selected for this study as they are the first cells of the immune system 
encountered by nanoparticles in mammals [16]. The cell viability assessment demonstrated 
that P-BNNTs do not cause adverse effects on macrophage culture after 24 h of treatment up 
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to 50 μg/ml. Moreover, necrotic/apoptotic phenomena and oxidative stress production were 
excluded as well. These data are in contrast with the results of Horvàth et al., which showed 
BNNT cytotoxicity in several cell lines, including macrophages, already at low concentrations 
(2 µg/ml). However, this cell impairment was probably due to the use of long nanotubes 
(10 μm), known to elicit strong toxic reactions during the cellular internalization process [31]. 
For the first time, we approached immune compatibility of BNNTs. The immune system 
protects the organism in first instance owing to phagocytic cells (among which macrophages), 
that take up harmful agents and release cytokines to preserve body homeostasis [32]. 
Nanoparticles, once internalized by immune cells, are rapidly excreted from the systemic 
circulation, that decreases their availability at the target site [33]. Moreover, cytokine secreted 
by immune cells as a consequence of a foreign body reaction could start a harmful 
inflammation process for the organism [34]. Several kinds of nanoparticles that induce 
adverse immune reactions were reported in the literature. As an example, titanium dioxide 
nanoparticles (up to 10 mg/kg) which were daily injected in mice for 90 days caused 
inflammation of kidneys, as demonstrated by the increment of inflammatory cytokines, such 
as TNF-α, MIF, IL-2, IL-4, IL-6, IL-8, IL-10, IL-18, IL-1β, TGF-β, INF-γ, both at gene and 
protein level [35]. Aluminum oxide nanoparticles, after 24 h since a single administration (10 
mg/kg) in mice, were proven to increase the blood level of IL-8 in comparison to the control 
animals [36]. It is therefore clear that a lack of undesirable inflammatory response is a priority 
for the application of nanoparticles in clinical treatments. 
In our study the analysis of the typical cytokines involved in the immune response was 
performed through ELISA and qPCR. The exposure to P-BNNTs for 24 h does not affect 
cytokine (IL-6, IL-10, TNF-α) release by macrophages. IL-6 is produced by macrophages in 
response to pathogens [37], activating a pro-inflammation cascade signaling together with 
TNF-α, which is the master regulator of pro-inflammatory cytokines production [38]. IL-10 is 
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an anti-inflammatory cytokine which restricts the immune response to danger agents in order 
to avoid damage to the organism [39]. 
Similarly to the ELISA results, the gene panel analysis revealed a marked difference among 
control and LPS-treated cultures. In particular, as expected, the LPS stimulation activates a 
molecular signaling typical of an inflammatory state [39-41]. The up-regulated genes 
comprise pro-inflammatoty cytokines (Tnfa, Il1a, Il1b, Il1rn, Il6, Il27), anti-inflammatory 
cytokines (Il10, Il11), chemokines (Ccl2, Ccl2, Ccl22, Ccl3, Ccl4, Ccl5, Ccl7, Cxcl1, Cxcl3, 
Pf4, Ppbp), and growth factors (Csf1, Csf2, Csf3, Lif, Osm, Vegfa). Among the down-
regulated genes we find chemokines (Ccl1, Ccl24, Cxcl1), interferon (Ifna2), interleukins (Il4, 
Il5), TNF receptors (Tnfrsf11b, Tnfsf10), and growth factors (Adipoq, MStn, Thpo). 
Conversely, no significant variations in gene transcription were observed following the P-
BNNT treatment, except for the down-regulation of the pro-inflammatoty cytokine Il1b. Il1b 
is secreted by activated macrophages and plays a key role in supporting phagocytosis of 
foreign bodies [42]. In a similar case, citrate-stabilized gold nanoparticles were found to 
inhibit Il1b and its down-stream responses both in vitro and in vivo [43]. Even though we are 
far to make any hypothesis about anti-inflammatory response following the administration of 
P-BNNTs (as we do not have significant reduction of any other inflammation marker), the 
decreasing expression of Il1b is interesting and worth of further investigations. 
Concerning P-BNNT/cell interaction, SEM observation demonstrated that P-BNNTs are 
strongly interacting with the cell membrane, resulting the nanoparticles extensively entrapped 
by microvilli. Upon internalization, nanotubes are confined within the endoplasmic 
compartment, without affecting the cell ultrastructure as confirmed by both TEM and 
confocal microscopy. BNNT internalization was well documented in many different kinds of 
cells [7], and in the case of RAW 264.7 we also confirmed an extensive nanoparticle uptake. 
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The lack of co-localization with lysosomes, however, suggests an early stage of the 
internalization process. 
Finally, we assessed mechanical properties of the cells following P-BNNT treatment, and 
SICM measurements revealed a considerably stiffer membrane in treated cells with respect to 
the controls. Conversely, in the literature it has been reported that nanoparticles can induce a 
reduction of membrane stiffness, as highlighted for manganese ferrite nanoparticles tested on 
RAW 264.7 [44]. In this study Roduit et al. performed AFM analysis on macrophages, 
suggesting that the membrane stiffness is reduced following a depolymerization of the 
cytoskeletal actin, necessary to increase the motility of the cells during the phagocytosis 
process. Our results are instead in line with the data previously obtained on stem cells treated 
with barium titanate nanoparticles [45], suggesting that a remodeling of the cytoskeleton 
following nanoparticle internalization leads to an increased membrane stiffness because of an 
increment of actin filaments surrounding the nanoparticles being internalized. 
5. Conclusion 
Potential immune response caused by nanoparticles should be carefully considered before any 
further exploitation in nanomedicine. This study preliminarily assessed immune compatibility 
of boron nitride nanotubes toward macrophage cultures. Overall, our data indicate that P-
BNNTs neither alter the macrophage growth no cause apoptosis and oxidative stress. 
Moreover, P-BNNTs, once internalized by cells, do not stimulate inflammation response both 
at protein and gene levels. In our opinion these results are extremely important, since they 
represent an encouraging fundamental step toward further preclinical testing of BNNTs. 
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Highlights  
 Pectin-coated boron nitride nanotubes (BNNTs) have been prepared and tested on 
RAW 264.7 macrophages. 
 This study represents the first investigation of BNNT immune compatibility.  
 Collected data indicate absence of acute toxicity and no adverse immune response. 
 The suitability of BNNTs for biomedical applications is confirmed. 
